Seroatlas · Human Serome Atlas

NAA38

N-alpha-acetyltransferase 38, NatC auxiliary subunit

Also known as: LSMD1, MGC14151, NAA38_HUMAN, PFAAP2

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
Q9BRA0
Gene
NAA38
Ensembl
ENSG00000183011
Chromosome
17
Canonical length
125 aa
Protein class
Predicted intracellular proteins
Subcellular location
Nucleoplasm

OverviewNCBI Gene

Predicted to enable RNA binding activity. Involved in negative regulation of apoptotic process. Located in cytoplasm and nucleoplasm. Part of NatC complex. [provided by Alliance of Genome Resources, Jul 2025]

Canonical amino-acid sequenceUniProt

125 residues, UniProt reviewed canonical sequence.

>Q9BRA0|NAA38
     1  MAGAGPTMLL REENGCCSRR QSSSSAGDSD GEREDSAAER ARQQLEALLN KTMRIRMTDG
    61  RTLVGCFLCT DRDCNVILGS AQEFLKPSDS FSAGEPRVLG LAMVPGHHIV SIEVQRESLT
   121  GPPYL

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against NAA38 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Intracellular
Secreted
No
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.49
Highest tissue expression
216 nTPM

Expression across tissuesHPA

Tissue

  • amygdala: 216 nTPM
  • basal ganglia: 192 nTPM
  • cerebral cortex: 182 nTPM
  • midbrain: 179 nTPM
  • choroid plexus: 169 nTPM
  • hippocampal formation: 159 nTPM

Single-cell type

  • megakaryocytes: 3,078 nCPM
  • late spermatids: 2,249 nCPM
  • epicardial cells: 992 nCPM
  • early spermatids: 803 nCPM
  • megakaryocyte progenitors: 666 nCPM
  • platelets: 569 nCPM

Immune cell

  • myeloid DC: 370 nTPM
  • basophil: 353 nTPM
  • total PBMC: 330 nTPM
  • plasmacytoid DC: 327 nTPM
  • classical monocyte: 325 nTPM
  • memory B-cell: 297 nTPM

Brain region

  • thalamus: 94 nTPM
  • cerebellum: 94 nTPM
  • basal ganglia: 89 nTPM
  • cerebral cortex: 89 nTPM
  • white matter: 87 nTPM
  • hypothalamus: 84 nTPM

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
1.49
gnomAD pLI
0.01
gnomAD missense Z
1.09
DepMap mean gene effect
-0.32
DepMap dependency class
selective

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads NAA38 as an antibody target. Whether an autoantibody or antibody against NAA38 could matter depends on whether native NAA38 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

NAA38 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label NAA38 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/NAA38. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...